The DOI matches its Crossref record; 109 of the 109 references it cites were found in a registry or an index.
Lipid-Based Nanoparticles: Application and Recent Advances in Cancer Treatment
Open accessAbstract
Many therapeutically active molecules are non-soluble in aqueous systems, chemically and biologically fragile or present severe side effects. Lipid-based nanoparticle (LBNP) systems represent one of the most promising colloidal carriers for bioactive organic molecules. Their current application in oncology has revolutionized cancer treatment by improving the antitumor activity of several chemotherapeutic agents. LBNPs advantages include high temporal and thermal stability, high loading capacity, ease of preparation, low production costs, and large-scale industrial production since they can be prepared from natural sources. Moreover, the association of chemotherapeutic agents with lipid nanoparticles reduces active therapeutic dose and toxicity, decreases drug resistance and increases drug levels in tumor tissue by decreasing them in healthy tissue. LBNPs have been extensively assayed in in vitro cancer therapy but also in vivo, with promising results in some clinical trials. This review summarizes the types of LBNPs that have been developed in recent years and the main results when applied in cancer treatment, including essential assays in patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
Ferlay, J., Colombet, M., Soerjomataram, I., Mathers, C., Parkin, D. M., Piñeros, M., Znaor, A., & Bray, F. (2019) · International Journal of Cancer · doi:10.1002/ijc.31937 · Cited by 7,553
Wang-Gillam, A., Li, C.-P., Bodoky, G., Dean, A., Shan, Y.-S., Jameson, G., Macarulla, T., Lee, K.-H., Cunningham, D., Blanc, J. F., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00986-1 · Cited by 1,222
Beg, M. S., Brenner, A. J., Sachdev, J., Borad, M., Kang, Y.-K., Stoudemire, J., Smith, S., Bader, A. G., Kim, S., & Hong, D. S. (2017) · Investigational New Drugs · doi:10.1007/s10637-016-0407-y · Cited by 897
Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come
Yingchoncharoen, P., Kalinowski, D. S., & Richardson, D. R. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.012070 · Cited by 744
Tapeinos, C., Battaglini, M., & Ciofani, G. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.08.033 · Cited by 539
Drug Resistance Driven by Cancer Stem Cells and Their Niche
Prieto-Vila, M., Takahashi, R.-U., Usuba, W., Kohama, I., & Ochiya, T. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122574 · Cited by 508
Noninvasive Imaging of Nanomedicines and Nanotheranostics: Principles, Progress, and Prospects
Kunjachan, S., Ehling, J., Storm, G., Kiessling, F., & Lammers, T. (2015) · Chemical Reviews · doi:10.1021/cr500314d · Cited by 480
Liposomal siRNA nanocarriers for cancer therapy
Ozpolat, B., Sood, A. K., & Lopez-Berestein, G. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.12.008 · Cited by 442
Passive and active targeting in cancer therapy by liposomes and lipid nanoparticles
Alavi, M., & Hamidi, M. (2019) · Drug Metabolism and Personalized Therapy · doi:10.1515/dmpt-2018-0032 · Cited by 405
Molecular mechanisms for tumour resistance to chemotherapy
Pan, S., Li, Z., He, Z., Qiu, J., & Zhou, S. (2016) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12581 · Cited by 401
Nanoparticle contrast agents for computed tomography: a focus on micelles
Cormode, D. P., Naha, P. C., & Fayad, Z. A. (2014) · Contrast Media & Molecular Imaging · doi:10.1002/cmmi.1551 · Cited by 362
Nanoparticle-based delivery of small interfering RNA: challenges for cancer therapy
Gulino, A. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s23696 · Cited by 258
Meng, J., Guo, F., Xu, H., Liang, W., Wang, C., & Yang, X.-D. (2016) · Scientific Reports · doi:10.1038/srep22390 · Cited by 236
In vitro and in vivo evaluation of cubosomes containing 5-fluorouracil for liver targeting
Nasr, M., Ghorab, M. K., & Abdelazem, A. (2015) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2014.12.001 · Cited by 223
Hyaluronic acid derivative-coated nanohybrid liposomes for cancer imaging and drug delivery
Park, J.-H., Cho, H.-J., Yoon, H. Y., Yoon, I.-S., Ko, S.-H., Shim, J.-S., Cho, J.-H., Park, J. H., Kim, K., Kwon, I. C., et al. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.11.016 · Cited by 221
Angelova, A., Garamus, V. M., Angelov, B., Tian, Z., Li, Y., & Zou, A. (2017) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2017.04.006 · Cited by 211
Current Trends in Cancer Nanotheranostics: Metallic, Polymeric, and Lipid-Based Systems
Silva, C. O., Pinho, J. O., Lopes, J. M., Almeida, A. J., Gaspar, M. M., & Reis, C. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11010022 · Cited by 210
Molecular mechanisms of drug resistance in ovarian cancer
Norouzi‐Barough, L., Sarookhani, M. R., Sharifi, M., Moghbelinejad, S., Jangjoo, S., & Salehi, R. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26289 · Cited by 200
Lakkadwala, S., & Singh, J. (2019) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2018.09.047 · Cited by 194
Advances in nanocarriers enabled brain targeted drug delivery across blood brain barrier
Sharma, G., Sharma, A. R., Lee, S.-S., Bhattacharya, M., Nam, J.-S., & Chakraborty, C. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.01.056 · Cited by 192
Biomarkers and therapeutic advances in glioblastoma multiforme
Sasmita, A. O., Wong, Y. P., & Ling, A. P. K. (2017) · Asia-Pacific Journal of Clinical Oncology · doi:10.1111/ajco.12756 · Cited by 184
Management of side effects during and post-treatment in breast cancer survivors
Palesh, O. G., Scheiber, C., Kesler, S. R., Mustian, K. M., Koopman, C., & Schapira, L. (2017) · The Breast Journal · doi:10.1111/tbj.12862 · Cited by 179
PolyMetformin combines carrier and anticancer activities for in vivo siRNA delivery
Zhao, Y., Wang, W., Guo, S., Wang, Y., Miao, L., Xiong, Y., & Huang, L. (2016) · Nature Communications · doi:10.1038/ncomms11822 · Cited by 171
Barani, M., Mirzaei, M., Torkzadeh‐Mahani, M., & Nematollahi, M. H. (2018) · DARU Journal of Pharmaceutical Sciences · doi:10.1007/s40199-018-0207-3 · Cited by 162
Low, L. E., Tan, L. T.-H., Goh, B.-H., Tey, B. T., Ong, B. H., & Tang, S. Y. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.01.037 · Cited by 159
Shi, S., Han, L., Deng, L., Zhang, Y., Shen, H., Gong, T., Zhang, Z., & Sun, X. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.09.005 · Cited by 158
Nanomedicines for Cancer Therapy: Current status, Challenges and Future Prospects
Bor, G., Azmi, I. D. M., & Yaghmur, A. (2019) · Therapeutic Delivery · doi:10.4155/tde-2018-0062 · Cited by 157
Shen, M., Liu, T., Yu, T.-W., Kv, R., Chiang, W., Tsai, Y.-C., Chen, H., Lin, S., & Chiu, H. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.01.019 · Cited by 156
Theranostic barcoded nanoparticles for personalized cancer medicine
Yaari, Z. A., da Silva, D., Zinger, A., Goldman, E., Kajal, A., Tshuva, R., Barak, E., Dahan, N., Hershkovitz, D., Goldfeder, M., et al. (2016) · Nature Communications · doi:10.1038/ncomms13325 · Cited by 153
Cellular uptake, cytotoxicity and in-vivo evaluation of Tamoxifen citrate loaded niosomes
Shaker, D. S., Shaker, M. A., & Hanafy, M. S. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.07.041 · Cited by 143
Anticancer Effects of Resveratrol-Loaded Solid Lipid Nanoparticles on Human Breast Cancer Cells
Wang, W., Zhang, L., Chen, T., Guo, W. Z., Bao, X., Wang, D., Ren, B., Wang, H., Li, Y., Wang, Y., et al. (2017) · Molecules · doi:10.3390/molecules22111814 · Cited by 135
A pH‐Responsive Drug‐Delivery Platform Based on Glycol Chitosan–Coated Liposomes
Yan, L., Crayton, S. H., Thawani, J. P., Amirshaghaghi, A., Tsourkas, A., & Cheng, Z. (2015) · Small · doi:10.1002/smll.201501412 · Cited by 131
Zielińska, A., Martins‐Gomes, C., Ferreira, N. R., Silva, A. M., Nowak, I., & Souto, E. B. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.10.065 · Cited by 127
Garg, N. K., Singh, B., Jain, A., Nirbhavane, P., Sharma, R. K., Tyagi, R. K., Kushwah, V., Jain, S., & Katare, O. P. (2016) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2016.05.051 · Cited by 124
Kadari, A., Pooja, D., Ravuri, H. G., Gudem, S., KOLAPALLI, V. R. M., Kulhari, H., & Sistla, R. (2018) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2018.09.012 · Cited by 124
Serini, S., Cassano, R., Corsetto, P. A., Rizzo, A. M., Calviello, G., & Trombino, S. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020586 · Cited by 123
Folic acid-modified liposomal drug delivery strategy for tumor targeting of 5-fluorouracil
Moghimipour, E., Rezaei, M., Ramezani, Z., Kouchak, M., Amini, M., Angali, K. A., Dorkoosh, F. A., & Handali, S. (2017) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2017.12.011 · Cited by 122
Zhang, J., Xiao, X. S., Zhu, J., Gao, Z., Lai, X., Zhu, X., & Mao, G. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s161163 · Cited by 118
Deshpande, P. P., Jhaveri, A. M., Pattni, B. S., Biswas, S., & Torchilin, V. P. (2018) · Drug Delivery · doi:10.1080/10717544.2018.1435747 · Cited by 116
Li, Y., Xiao, Y., Lin, H.-P., Reichel, D., Bae, Y., Lee, E. Y., Jiang, Y., Huang, X., Yang, C., & Wang, Z. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.10.019 · Cited by 116
Grillone, A. F., Riva, E. R., Mondini, A., Forte, C., Calucci, L., Innocenti, C., Fernández, C. D. J., Cappello, V., Gemmi, M., Moscato, S., et al. (2015) · Advanced Healthcare Materials · doi:10.1002/adhm.201500235 · Cited by 115
Function of oncogenes in cancer development: a changing paradigm
Vicente‐Dueñas, C., Romero-Camarero, I., Cobaleda, C., & Sánchez-García, I. (2013) · The EMBO Journal · doi:10.1038/emboj.2013.97 · Cited by 112
Ramadass, S. K., Anantharaman, N. V., Subramanian, S., Sivasubramanian, S., & Madhan, B. (2014) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2014.11.005 · Cited by 112
Magnetic liposomes for colorectal cancer cells therapy by high-frequency magnetic field treatment
Hardiansyah, A., Huang, L., Yang, M., Liu, T.-Y., Tsai, S.-C., Yang, C., Kuo, C., Chan, T., Zou, H.-M., Lian, W.-N., et al. (2014) · Nanoscale Research Letters · doi:10.1186/1556-276x-9-497 · Cited by 112
Baek, J.-S., & Cho, C. (2017) · Oncotarget · doi:10.18632/oncotarget.16153 · Cited by 108
Saber, M. M., Al-mahallawi, A. M., Nassar, N. N., Stork, B., & Shouman, S. A. (2018) · BMC Cancer · doi:10.1186/s12885-018-4727-5 · Cited by 102
Ektate, K., Munteanu, M. C., Ashar, H. K., Malayer, J. R., & Ranjan, A. (2018) · Scientific Reports · doi:10.1038/s41598-018-30106-4 · Cited by 101
Papachristodoulou, A., Signorell, R. D., Werner, B., Brambilla, D., Luciani, P., Çavuşoğlu, M., Grandjean, J., Silginer, M., Rudin, M., Martin, E., et al. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.12.009 · Cited by 99
Magnetic delivery of antitumor carboplatin by using PEGylated-Niosomes
Davarpanah, F., Yazdi, A. K., Barani, M., Mirzaei, M., & Torkzadeh‐Mahani, M. (2018) · DARU Journal of Pharmaceutical Sciences · doi:10.1007/s40199-018-0215-3 · Cited by 94
Glassman, D. C., Palmaira, R. L. D., Covington, C. M., Desai, A. M., Ku, G. Y., Li, J., Harding, J. J., Varghese, A. M., O'Reilly, E. M., & Yu, K. H. (2018) · BMC Cancer · doi:10.1186/s12885-018-4605-1 · Cited by 92
FA-loaded lipid drug delivery systems: Preparation, characterization and biological studies
Carbone, C., Campisi, A., Musumeci, T., Raciti, G., Bonfanti, R., & Puglisi, G. (2013) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.10.003 · Cited by 90
Jyoti, K., Kaur, K., Pandey, R. S., Jain, U. K., Chandra, R., & Madan, J. (2015) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2014.12.092 · Cited by 90
Hu, H., Xiao, C., Wu, H., Li, Y., Zhou, Q., Tang, Y., Yu, C., Yang, X., & Li, Z. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b14796 · Cited by 89
Lipid-based nanoparticles for cancer treatment
Obeid, M. A., Tate, R. J., Mullen, A. B., & Ferro, V. A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813687-4.00008-6 · Cited by 89
Docosahexaenoic acid–mediated, targeted and sustained brain delivery of curcumin microemulsion
Shinde, R. L., & Devarajan, P. V. (2017) · Drug Delivery · doi:10.1080/10717544.2016.1233593 · Cited by 88
Wonder, E. A., Simón‐Gracia, L., Scodeller, P., Majzoub, R. N., Kotamraju, V. R., Ewert, K. K., Teesalu, T., & Safinya, C. R. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2018.02.052 · Cited by 86
Lipid Nanoparticles and their Application in Nanomedicine
Rajabi, M., & Mousa, S. A. (2016) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201017666160415155457 · Cited by 85
Li, S., Wang, L., Li, N., Liu, Y., & Su, H. C. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.08.090 · Cited by 85
Jiang, H., Geng, D., Liu, H., Li, Z., & Cao, J. (2016) · Drug Delivery · doi:10.1080/10717544.2016.1217954 · Cited by 83
Xu, L., Qu, C.-Y., Zhou, M., Chen, Y., Chen, M., & Shen, F. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s83211 · Cited by 82
Wang, J., Zhu, R., Sun, X., Wang, T., Liu, H., & Wang, S. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s64103 · Cited by 82
Sorafenib and gadolinium co-loaded liposomes for drug delivery and MRI-guided HCC treatment
Xiao, Y., Liu, Y., Yang, S., Zhang, B., Wang, T., Jiang, D., Zhang, J., Yu, D., & Zhang, N. (2016) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2016.01.016 · Cited by 82
Lakkadwala, S., & Singh, J. (2018) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2018.07.020 · Cited by 82
Sesărman, A., Tefas, L. R., Sylvester, B., Licărete, E., Rauca, V. F., Lupuţ, L., Pătraș, L., Porav, A. S., Banciu, M., & Porfire, A. S. (2018) · Drug Delivery and Translational Research · doi:10.1007/s13346-018-00598-8 · Cited by 81
Rajput, S., Puvvada, N., Kumar, B. N. P., Sarkar, S., Konar, S., Bharti, R., Dey, G., Mazumdar, A., Pathak, A., Fisher, P. B., et al. (2015) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00692 · Cited by 80
Li, X., Jia, X., & Hu, N. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s163929 · Cited by 80
Cao, X., Luo, J., Gong, T., Zhang, Z., Sun, X., & Fu, Y. S. (2014) · Molecular Pharmaceutics · doi:10.1021/mp500637b · Cited by 79
Triggered release of paclitaxel from magnetic solid lipid nanoparticles by magnetic hyperthermia
Oliveira, R. R., Carrião, M. S., Pacheco, M. T., Branquinho, L. C., de Souza, A. L. R., Bakuzis, A. F., & Lima, E. M. (2018) · Materials Science and Engineering C · doi:10.1016/j.msec.2018.07.011 · Cited by 78
Kumar, A., Ahuja, A., Ali, J., & Baboota, S. (2016) · Drug Delivery · doi:10.3109/10717544.2014.909906 · Cited by 76 · cited 10×
“Cancer Type NP Type Target Drug or Cargo SS Detection Method Combined Therapy Status Reference Pancreatic ME Cur Stearoyl chitosan Optical microscopy SEM IVT + IVV [68] NE Gemcitabine γ-tocotrienol isomerof vitamin E IVT [69] PE Neu1 OsP IVT [70] Liposome NF-kappaB EF24 PEG TEM Gemcitabine IVT + IVV [71] Liposome HSA-…”
BackgroundInfluentialUltrasound-mediated drug delivery using liposomes modified with a thermosensitive polymer
Ninomiya, K., Kawabata, S., Tashita, H., & Shimizu, N. (2013) · Ultrasonics Sonochemistry · doi:10.1016/j.ultsonch.2013.07.014 · Cited by 69
Raucher, D., Dragojevic, S., & Ryu, J.-S. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00624 · Cited by 68
Tian, Y., Li, J., Zhu, J., Zhu, N., Zhang, H., Liang, L., & Sun, L. (2017) · Medical Science Monitor · doi:10.12659/msm.904683 · Cited by 67
Chang, M., Wu, M., & Li, H. (2018) · Drug Delivery · doi:10.1080/10717544.2018.1526227 · Cited by 67
Rouholamini, S. E. Y., Moghassemi, S., Maharat, Z., Hakamivala, A., Kashanian, S., & Omidfar, K. (2017) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2017.1326928 · Cited by 66
Wei, Y., Wang, Y.-X., Xia, D., Guo, S., Wang, F., Zhang, X., & Gan, Y. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b07132 · Cited by 66
Cancer theranostic applications of lipid-based nanoparticles
Tang, W.-L., Tang, W.-H., & Li, S. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.04.007 · Cited by 66
Ye, F., Gao, Y., Wang, D., Xu, Z., Sun, W., & Ren, P. (2018) · Nanoscale Research Letters · doi:10.1186/s11671-018-2716-x · Cited by 66
Cancer survivorship: long-term side-effects of anticancer treatments of gastrointestinal cancer
Numico, G., Longo, V., Courthod, G., & Silvestris, N. (2015) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000203 · Cited by 64
Ahmad, G., Sadda, R. R. E., Botchkina, G. I., Ojima, I., Egan, J., & Amiji, M. M. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.08.004 · Cited by 63
Rahiminejad, A., Dinarvand, R., Johari, B., Nodooshan, S. J., Rashti, A., Rismani, E., Mahdaviani, P., Saltanatpour, Z., Rahiminejad, S., Raigani, M., et al. (2018) · Cell Biology International · doi:10.1002/cbin.11037 · Cited by 60
A phase 1 trial of intravenous liposomal irinotecan in patients with recurrent high-grade glioma
Clarke, J. L., Molinaro, A. M., Cabrera, J. R., DeSilva, A. A., Rabbitt, J. E., Prey, J. D., Drummond, D. C., Kim, J., Noble, C. O., Fitzgerald, J. B., et al. (2017) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-017-3247-3 · Cited by 58
Wan, K., Sun, L., Hu, X., Yan, Z., Zhang, Y., Zhang, X., & Zhang, J. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.03.055 · Cited by 57
Liang, T., Yao, Z., Ding, J., Min, Q., Jiang, L., & Zhu, J. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b14009 · Cited by 56
Pindiprolu, S. K. S. S., Chintamaneni, P. K., Krishnamurthy, P. T., & Sri, G. K. R. (2018) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2018.1539496 · Cited by 56
Liang, Y., Tian, B., Zhang, J., Li, K., Wang, L., Han, J., & Wu, Z. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s121262 · Cited by 55
Chen, T., Gong, T., Zhao, T., Fu, Y. N., Zhang, Z., & Gong, T. (2017) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2017.09.041 · Cited by 55
Nassir, A. M., Ibrahim, I. A. A., Md, S., Waris, M., ., T., Ain, M. R., Ahmad, I., & Shahzad, N. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.01.053 · Cited by 55
Yu, D., Li, W., Zhang, Y., & Zhang, B. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.08.061 · Cited by 52
Tian, Y., Zhang, H., Qin, Y., Li, D., Liu, Y., Wang, H., & Gan, L. (2018) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2018.1512613 · Cited by 51
Chastagner, P. B., Devictor, B., Geoerger, B., Aerts, I., Leblond, P., Frappaz, D., Gentet, J., Bracard, S., & André, N. (2015) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-015-2781-0 · Cited by 46
pH-sensitive, polymer modified, plasma stable niosomes: promising carriers for anti-cancer drugs
Tila, D., Yazdani-Arazi, S. N., Ghanbarzadeh, S., Arami, S., & Pourmoazzen, Z. (2015) · EXCLI journal · doi:10.17179/excli2013-609 · Cited by 44
Eskiler, G. G., Çeçener, G., Egelí, Ü., & Tunca, B. (2018) · Pharmaceutical Research · doi:10.1007/s11095-018-2502-6 · Cited by 44
Abu‐Fayyad, A., & Nazzal, S. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.06.031 · Cited by 43
Li, T., Zhang, Y., Meng, Y.-P., Bo, L.-S., & Ke, W. (2017) · Pharmaceutical Research · doi:10.1007/s11095-017-2202-7 · Cited by 40
Haron, A. S., Alwi, S. S. S., Yazan, L. S., Razak, R. A., Ong, Y. S., Ansar, F. H. Z., & Alexander, H. R. (2018) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2018/1549805 · Cited by 38
Targeting effect of PEGylated liposomes modified with the Arg-Gly-Asp sequence on gastric cancer
Ding, J., Feng, M., Wang, F., Wang, H., & Guan, W. (2015) · Oncology Reports · doi:10.3892/or.2015.4142 · Cited by 37
Negi, L. M. S., Talegaonkar, S., Jaggi, M., Verma, A. K., Verma, R., Dobhal, S., & Kumar, V. (2014) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2014.09.062 · Cited by 36
Lipka, D., Legut, M., Filipczak, N., Gubernator, J., Piwoni, A., & Kozubek, A. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s54911 · Cited by 35
Fahmy, U. A. (2018) · AAPS PharmSciTech · doi:10.1208/s12249-018-1199-5 · Cited by 35
Yang, F., Zheng, Z., Zheng, L., Qin, J., Li, H., Xue, X., Gao, J., & Fang, G.-E. (2018) · OncoTargets and Therapy · doi:10.2147/ott.s182437 · Cited by 34
Multifunctional Magnetic Liposomes for Cancer Imaging and Therapeutic Applications
Gogoi, M., Kumar, N., & Patra, S. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-47347-7.00027-6 · Cited by 32
Archaeosome: As New Drug Carrier for Delivery of Paclitaxel to Breast Cancer
Alavi, S. E., Mansouri, H., Esfahani, M. K. M., et al. (2013) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-013-0305-4 · Cited by 29
Amiri, B., & Ebrahimifar, M. (2016) · PubMed · doi:10.14456/apjcp.2016.178 · Cited by 27
Ma, L., Yang, D., Li, Z., Zhang, X., & Pu, L. (2018) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2018.1472101 · Cited by 26
Behroozeh, A., Tabrizi, M. M., Kazemi, S. M., Choupani, E., Kabiri, N., Ilbeigi, D., Nasab, A. H., Khiyavi, A. A., & Kurdi, A. A. S. (2018) · PubMed Central · doi:10.22034/apjcp.2018.19.3.645 · Cited by 25
Wang, L., Huang, S., Guo, H., Han, Y., Zheng, W., & Jiang, J. (2016) · Drug Design Development and Therapy · doi:10.2147/dddt.s111351 · Cited by 24
Chen, Y.-J., Chang, C.-H., Chi, C., Yu, H.-L., Chang, T.-J., Tsai, T., Lee, T., & Liu, S. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s80302 · Cited by 18
Zhang, X., Lin, C.-C., Chan, W.-K.-N., Liu, K., Yang, Z., & Zhang, H. (2017) · Molecules · doi:10.3390/molecules22071052 · Cited by 16
Cited by
Tenchov, R., Bird, R., Curtze, A. E., & Zhou, Q. (2021) · ACS Nano · doi:10.1021/acsnano.1c04996 · Cited by 2,221
Breast cancer: Biology, biomarkers, and treatments
Barzaman, K., Karami, J., Zarei, Z., Hosseinzadeh, A., Kazemi, M. H., Moradi-Kalbolandi, S., Safari, E., & Farahmand, L. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106535 · Cited by 973
Specific targeting cancer cells with nanoparticles and drug delivery in cancer therapy
Raj, S., Khurana, S., Choudhari, R., Kesari, K. K., Kamal, M. A., Garg, N., Ruokolainen, J., Das, B. C., & Kumar, D. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.11.002 · Cited by 425
Recent Progress in Nanostructured Smart Drug Delivery Systems for Cancer Therapy: A Review
Khan, M. I., Hossain, M. I., Hossain, M. K., Rubel, M. H. K., Hossain, K. M., Mahfuz, A. M. U. B., & Anik, M. I. (2022) · ACS Applied Bio Materials · doi:10.1021/acsabm.2c00002 · Cited by 370
Advancements in nanoparticle-based treatment approaches for skin cancer therapy
Zeng, L., Gowda, B. H. J., Ahmed, M. G., Abourehab, M. A. S., Chen, Z.-S., Zhang, C., Li, J., & Kesharwani, P. (2023) · Molecular Cancer · doi:10.1186/s12943-022-01708-4 · Cited by 365
Metadata
- Authors
- García-Pinel, B., Porras-Alcalá, C., Ortega-Rodríguez, A., Sarabia, F., Prados, J., Melguizo, C., & López-Romero, J. M.
- Venue
- Nanomaterials
- Publisher
- MDPI AG
- Published
- 2019-04-19
- Volume
- 9
- Issue
- 4
- Pages
- 638
- ISSN
- 2079-4991 (ISSN-L)
- OpenAlex
- W2936858823
- Cited by
- 527
- References
- 109
- FWCI
- 13.21
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.